Tectonic Therapeutic, Inc.
TECX
DELAYED 1 MONTH

14 insider filings · Latest: Jun 9, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 4, 2026May 6 9:00 PMMarcella K. RuddyChief Medical Officer
Sale
1,065$30.00$31.9K67,682(D)

View →

Mar 6, 2026Mar 9 10:15 PMMarcella K. RuddyChief Medical Officer
Sale
10,000$30.00$300.0K69,747(D)

View →

Mar 6, 2026Mar 9 10:12 PMPeter McnamaraChief Scientific Officer
Sale
6,262$30.17$188.9K55,285(D)

View →

Mar 4, 2026Mar 5 10:45 PMPeter McnamaraChief Scientific Officer
Sale
1,650$25.00$41.3K58,832(D)

View →

Mar 3, 2026Mar 5 10:45 PMPeter McnamaraChief Scientific Officer
Sale
1,649$22.06$36.4K37,482(D)

View →

Feb 11, 2026Mar 5 9:30 PMAlise ReicinDirector, Chief Executive Officer
Purchase
2,500$21.10$52.8K127,030(I)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 9, 2026Jun 10 8:45 PMSPRINGER TIMOTHY ADirector, 10% Owner
Grant/Award
10,200$28.5610,200(D)

View →

Jun 9, 2026Jun 10 8:45 PMPraveen P. TipirneniDirector
Grant/Award
10,200$28.5610,200(D)

View →

Jun 9, 2026Jun 10 8:45 PMPhillip B. DonenbergDirector
Grant/Award
10,200$28.5610,200(D)

View →

Jun 9, 2026Jun 10 8:45 PMStefan VitorovicDirector
Grant/Award
10,200$28.5610,200(D)

View →

Jun 8, 2026Jun 10 8:36 PMJessica Caroline ChutterDirector
Grant/Award
20,400$29.1020,400(D)

View →

Mar 6, 2026Mar 9 10:12 PMPeter McnamaraChief Scientific Officer
Option Exercise
2,715$14.718,045(D)

View →

Mar 4, 2026Mar 5 10:47 PMAlise ReicinDirector, Chief Executive Officer
Grant/Award
69,250$27.4169,250(D)

View →

Mar 4, 2026Mar 5 10:46 PMMarc SchwabishChief Business Officer
Grant/Award
17,750$27.4117,750(D)

View →

Mar 4, 2026Mar 5 10:45 PMPeter McnamaraChief Scientific Officer
Grant/Award
21,000$27.4121,000(D)

View →

Mar 4, 2026Mar 5 10:43 PMDaniel LochnerChief Financial Officer
Grant/Award
24,250$27.4124,250(D)

View →

Mar 4, 2026Mar 5 10:42 PMMarcella K. RuddyChief Medical Officer
Grant/Award
24,250$27.4124,250(D)

View →